Metagenomi Therapeutics, Inc. Shareholders' Equity
Metagenomi Therapeutics, Inc. (MGX) had Shareholders' Equity of $112.57 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $112.57M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $137.78M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $158.60M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $178.45M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $112.57M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $137.78M 10-Q · filed 2026-08-10 |
| 2025-12-31 | $158.60M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $178.45M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $195.83M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $212.66M 10-Q · filed 2026-08-10 |
| 2024-12-31 | $234.86M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $255.77M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $269.42M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $275.63M 10-Q · filed 2025-11-12 |
| 2023-12-31 | -$135.58M 10-K · filed 2026-03-05 |
| 2023-09-30 | -$119.02K 10-Q · filed 2024-11-13 |
| 2023-06-30 | -$102.54M 10-Q · filed 2024-11-13 |
| 2023-03-31 | -$90.01M 10-Q · filed 2024-11-13 |
| 2022-12-31 | -$74.43M 10-K · filed 2025-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |